A binding protein used in laboratory research exploring growth-factor regulation and cellular signalling control

Follistatin-344 5 mg from SEMPICA HEALTHCARE is supplied as a laboratory-prepared research material, presented in a sealed pen format with a fixed and clearly defined composition. It is intended solely for research and development purposes and is provided without instructions, protocols, or advice.

This product is not a medicine, not a treatment, and not intended for human or animal use. By purchasing, you accept full responsibility for how it is stored, handled, and used within your own research setting.

What Follistatin-344 Is (Explained Simply)

Follistatin-344 is a naturally occurring binding protein, rather than a traditional signalling peptide. Instead of activating receptors directly, it is studied for its ability to bind to and regulate other signalling molecules, particularly members of the transforming growth factor-beta (TGF-β) superfamily.

In simple terms, Follistatin-344 is researched because it acts as a regulatory control protein, influencing how certain growth-related signals are moderated within cellular environments. This makes it fundamentally different from peptides designed to stimulate pathways directly.

Why Follistatin-344 Is Studied

Follistatin-344 has been examined in laboratory research relating to:

• Growth-factor binding and regulation
• Activin and myostatin signalling control
• Cellular differentiation processes
• Tissue signalling balance and modulation
• Differences between signalling peptides and binding proteins

Published research has reported notable observations in growth-factor regulation and cellular signalling studies, which is why Follistatin-344 continues to attract attention in academic and laboratory settings.

These findings are referenced only to explain research interest.
They do not relate to this product being sold and do not imply any effect, outcome, or intended use.

How Follistatin-344 Differs From Other Peptides

Unlike receptor-activating peptides or hormones, Follistatin-344 is studied for its indirect regulatory role. Rather than initiating signals, it modulates the availability and activity of other signalling molecules.

Researchers are particularly interested in:

• How binding proteins influence signalling intensity
• The balance between activation and inhibition within growth pathways
• Differences between regulatory control proteins and direct agonists
• The role of binding proteins in maintaining cellular signalling equilibrium

This places Follistatin-344 firmly within foundational regulatory and mechanistic research, rather than outcome-driven studies.

Why a 5 mg Format Is Used

The 5 mg Follistatin-344 format is commonly chosen for:

• Highly controlled laboratory studies
• Research involving potent binding proteins
• Comparative signalling and regulation experiments
• Laboratories requiring precision with minimal material excess

Because binding proteins can exert significant regulatory influence at low quantities, a 5 mg format supports careful experimental design and control.

How This Product Is Supplied

SEMPICA HEALTHCARE supplies Follistatin-344 1 mg as:

• A laboratory-prepared liquid solution
• Pre-mixed in 3 ml bacteriostatic water
• Sealed in a pen format for controlled handling
• Clearly labelled with known content and volume

This removes the need for manual preparation and reduces variability between research runs.

Technical Information

Compound name: Follistatin-344
Category: Binding protein (research grade)
Molecular type: Growth-factor binding protein
Purity: ≥ 99 %
Net content: 5 mg
Solvent: 3 ml bacteriostatic water
Appearance: Clear liquid
Solution colour: Clear
Format: Factory-sealed research pen

This information is provided so purchasers know exactly what the compound is.

What Is Included

Each Follistatin-344 5 mg Research Pen includes:

• One pre-mixed Follistatin-344 5 mg research pen
• Individually sealed microneedles (research handling only)
• Alcohol swabs
• Printed storage and preservation notes

No instructions, dosing guidance, or research protocols are supplied.

Storage and Preservation Notes

• Store refrigerated when not in use
• Do not freeze
• Avoid direct or indirect sunlight
• Keep sealed when not being handled
• Inspect visually; solution should remain clear

These notes exist only to help preserve material integrity, not to guide use.

Related Research Products

Follistatin-344 is often purchased alongside other research materials such as IGF-related peptides, Sermorelin, CJC-1295, MOTS-c, or GHK-Cu to support broader growth-factor and regulatory signalling research work.

SEMPICA HEALTHCARE does not recommend combinations or provide guidance. All decisions remain with the purchaser.

About SEMPICA HEALTHCARE

SEMPICA HEALTHCARE supplies clearly described, laboratory-prepared research materials for buyers who value transparency, consistency, and straightforward information.

We provide the product.
How it is used is entirely your responsibility.

Important Research Use Notice

This product is supplied strictly for research and development purposes only.

It is not intended to:

• Diagnose, treat, cure, or prevent any disease
• Be used on or by humans or animals
• Be represented as a medicine, supplement, or injectable product

SEMPICA HEALTHCARE provides no guidance, plans, protocols, or advice beyond the information published here.

By purchasing, you confirm that you accept full responsibility for use, storage, handling, and regulatory compliance.

Buy Follistatin-344 5 mg Research Pen

Order Follistatin-344 5 mg Research Pen Online